[{"Assets_0_Q3_USD":"456775000.0","CIK":"1023024","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"0.32","EarningsPerShareBasic_3_Q3_USD":"0.91","EarningsPerShareDiluted_1_Q3_USD":"0.32","EarningsPerShareDiluted_3_Q3_USD":"0.89","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"569805985.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"40828000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"3832000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"10753000.0","NetIncomeLoss_1_Q3_USD":"3895000.0","NetIncomeLoss_3_Q3_USD":"10929000.0","OfficialName":"ANI Pharmaceuticals Inc.","RevenuesConverted_1_Q3_USD":"51337000.0","RevenuesConverted_3_Q3_USD":"158581000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"213130000.0","Ticker":"ANIP","TreasuryStockSharesConverted_0_Q3_shares":"12311.0","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"12085000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"12060000.0","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":"11879000.0","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":"11826000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"11879000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"11826000.0","filed":"20191106","footnote":null,"form":"10-Q","fp":"Q3","fy":"2019.0","name":"ANI PHARMACEUTICALS INC","period":"20190930","qtrs":"0","uom":"USD"}]